[1] |
Gittleman H, Cioffi G, Vecchione-Koval T, et al. Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the united states from 2006 to 2015[J]. J Neurooncol, 2019, 143(2): 251-260. DOI: 10.1007/s11060-019-03173-4.
|
[2] |
Echevarría ME, Fangusaro J, Goldman S. Pediatric central nervous system germ cell tumors: a review[J]. Oncologist, 2008, 13(6): 690-699. DOI: 10.1634/theoncologist.2008-0037.
|
[3] |
Kong Z, Wang Y, Dai C, et al. Central nervous system germ cell tumors: a review of the literature[J]. J Child Neurol, 2018, 33(9): 610-620. DOI: 10.1177/0883073818772470.
|
[4] |
Keene D, Johnston D, Strother D, et al. Epidemiological survey of central nervous system germ cell tumors in canadian children[J]. J Neurooncol, 2007, 82(3): 289-295. DOI: 10.1007/s11060-006-9282-2.
|
[5] |
Jennings MT, Gelman R, Hochberg F. Intracranial germ-cell tumors: Natural history and pathogenesis[J]. J Neurosurg, 1985, 63(2): 155-167. DOI: 10.3171/jns.1985.63.2.0155.
|
[6] |
Lee SH, Jung KW, Ha J, et al. Nationwide population-based incidence and survival rates of malignant central nervous system germ cell tumors in Korea, 2005-2012[J]. Cancer Res Treat, 2017, 49(2): 494-501. DOI: 10.4143/crt.2016.129.
|
[7] |
Skakkebaek NE, Berthelsen JG, Giwercman A, et al. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma[J]. Int J Androl, 1987, 10(1): 19-28. DOI: 10.1111/j.1365-2605.1987.tb00161.x.
|
[8] |
Alves AS, Scampa M, Martineau J, et al. Decreased incidence of merkel cell carcinoma in the younger population (below 50) in the United States: SEER analysis 2000-2019[J]. J Am Acad Dermatol, 2023. DOI: 10.1016/j.jaad.2023.04.008.
|
[9] |
Price B. Projection of future numbers of mesothelioma cases in the US and the increasing prevalence of background cases: an update based on SEER data for 1975 through 2018[J]. Crit Rev Toxicol, 2022, 52(4): 317-324. DOI: 10.1080/10408444.2022.2082919.
|
[10] |
Chen L, Ma J, Zou Z, et al. Clinical characteristics and prognosis of patients with glioblastoma: a review of survival analysis of 1674 patients based on SEER database[J]. Medicine (Baltimore), 2022, 101(47): e32042. DOI: 10.1097/MD.0000000000032042.
|
[11] |
Alexopoulos G, Zhang J, Karampelas I, et al. Long-term time series forecasting and updates on survival analysis of glioblastoma multiforme: a 1975-2018 population-based study[J]. Neuroepidemiology, 2022, 56(2): 75-89. DOI: 10.1159/000522611.
|
[12] |
Cheng H, Xu JH, Kang XH, et al. Nomograms for predicting overall survival and cancer-specific survival in elderly patients with epithelial ovarian cancer[J]. J Ovarian Res, 2023, 16(1): 75. DOI: 10.1186/s13048-023-01144-y.
|
[13] |
Sclafani JJ, My J, Zacher LL, et al. Intensive education on evidence-based evaluation of syncope increases sudden death risk stratification but fails to reduce use of neuroimaging[J]. Arch Intern Med, 2010, 170(13): 1150-1154. DOI: 10.1001/archinternmed.2010.205.
|
[14] |
Nakajima K, Nakamura S, Hase H, et al. Risk stratification based on j-access risk models with myocardial perfusion imaging: risk versus outcomes of patients with chronic kidney disease[J]. J Nucl Cardiol, 2020, 27(1): 41-50. DOI: 10.1007/s12350-018-1330-8.
|
[15] |
Tseng JH, Tseng MY. Survival analysis of children with primary malignant brain tumors in england and wales: a population-based study[J]. Pediatr Neurosurg, 2006, 42(2): 67-73. DOI: 10.1159/000090458.
|
[16] |
Xie G, Qi C, Yang W, et al. Competing risk nomogram predicting cancer-specific mortality for endometrial cancer patients treated with hysterectomy[J]. Cancer Med, 2021, 10(10): 3205-3213. DOI: 10.1002/cam4.3887.
|
[17] |
Makino K, Nakamura H, Yano S, et al. Population-based epidemiological study of primary intracranial tumors in childhood[J]. Childs Nerv Syst, 2010, 26(8): 1029-1034. DOI: 10.1007/s00381-010-1126-x.
|
[18] |
Wong TT, Ho DM, Chang KP, et al. Primary pediatric brain tumors: statistics of Taipei VGH, Taiwan (1975-2004)[J]. Cancer, 2005, 104(10): 2156-2167. DOI: 10.1002/cncr.21430.
|
[19] |
Cho KT, Wang KC, Kim SK, et al. Pediatric brain tumors: statistics of SNUH, Korea (1959-2000)[J]. Childs Nerv Syst, 2002, 18(1-2): 30-37. DOI: 10.1007/s00381-001-0547-y.
|
[20] |
Matsutani M, Sano K, Takakura K, et al. Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases[J]. J Neurosurg, 1997, 86(3): 446-455. DOI: 10.3171/jns.1997.86.3.0446.
|
[21] |
Janmohamed S, Grossman AB, Metcalfe K, et al. Suprasellar germ cell tumours: specific problems and the evolution of optimal management with a combined chemoradiotherapy regimen[J]. Clin Endocrinol (Oxf), 2002, 57(4): 487-500. DOI: 10.1046/j.1365-2265.2002.01620.x.
|
[22] |
Aizer AA, Sethi RV, Hedley-Whyte ET, et al. Bifocal intracranial tumors of nongerminomatous germ cell etiology: diagnostic and therapeutic implications[J]. Neuro Oncol, 2013, 15(7): 955-960. DOI: 10.1093/neuonc/not050.
|
[23] |
Ogiwara H, Tsutsumi Y, Matsuoka K, et al. Apparent diffusion coefficient of intracranial germ cell tumors[J]. J Neurooncol, 2015, 121(3): 565-571. DOI: 10.1007/s11060-014-1668-y.
|
[24] |
Morana G, Alves CA, Tortora D, et al. T2*-based MR imaging (gradient echo or susceptibility-weighted imaging) in midline and off-midline intracranial germ cell tumors: a pilot study[J]. Neuroradiology, 2018, 60(1): 89-99. DOI: 10.1007/s00234-017-1947-3.
|
[25] |
Bhimani AD, Barrington NM, Aguilar TM, et al. Pituitary germinomas: a multi-institutional study analyzing patient demographics and management patterns[J]. Pituitary, 2020, 23(4): 381-388. DOI: 10.1007/s11102-020-01042-2.
|
[26] |
Che W, Wang Y, Zhou Y, et al. Epidemiology, management, and long-term survival outcomes of intracranial typical site germinomas: an analysis of the surveillance, epidemiology, and end-results (SEER) database[J]. Cancer Control, 2022, 29: 1-9. DOI: 10.1177/10732748221095944.
|
[27] |
|
[28] |
|